Intestinal Permeability and Metabolic Endotoxaemia
Intestinal permeability describes how readily the gut wall lets bacterial fragments through; a leakier barrier allows endotoxin into the blood, a state called metabolic endotoxaemia that accompanies the low-grade inflammation of obesity.
Plain English
Patient-Friendly Explanation
The lining of the gut is a barrier. A single layer of cells, sealed at their joins by protein structures called tight junctions, separated from the gut contents by a layer of mucus, decides what passes into the bloodstream and what stays behind. Small amounts of bacterial material do cross, and the immune system handles them. When the barrier becomes leakier, more of that bacterial material gets through. The most studied of these fragments is lipopolysaccharide, part of the outer wall of certain bacteria and also known as endotoxin. A two- to three-fold rise in circulating endotoxin, without any infection, is what researchers call metabolic endotoxaemia. Once in the blood, endotoxin binds to receptors on immune cells and switches on inflammatory pathways, and that inflammation interferes with insulin signalling. This is one proposed mechanism linking diet and gut bacteria to the low-grade inflammation, insulin resistance and fatty liver that accompany obesity. In humans the evidence is consistent but not conclusive. People with obesity show higher markers of gut permeability, and these markers correlate with the amount of fat around the abdominal organs, with fat in the liver, and with measures of insulin resistance. The barrier is influenced by what is eaten: diets high in fat, alcohol and ultra-processed food tend to increase permeability, while dietary fibre, resistant starch and fermented foods tend to support the barrier, partly because gut bacteria turn fibre into short-chain fatty acids that the gut lining uses as fuel. Several cautions are needed. The blood tests marketed for leaky gut, including zonulin, are not standardised and are debated even among researchers. Association does not prove cause, and trials that change the gut bacteria, including faecal transplants, have not produced weight loss. Where a genuine problem such as small intestinal bacterial overgrowth is documented, it is worth treating. Otherwise the sensible approach is the ordinary one: eat more fibre and less ultra-processed food, limit alcohol, lose weight if it is excessive, and be sceptical of supplements sold for gut repair.
Medical
Clinical Definition
Intestinal permeability is regulated by tight junction proteins including occludin, claudin family members and zonula occludens-1, together with the mucus layer and mucosal immune system. Increased permeability permits translocation of bacterial lipopolysaccharide into the circulation; the term metabolic endotoxaemia describes a two- to three-fold rise in plasma lipopolysaccharide in the absence of infection, and lipopolysaccharide signalling through TLR4 and CD14 activates NF-kB and JNK pathways, promoting inflammatory cytokine release and impairing insulin signalling. The concept originated in rodent work in which high-fat feeding increased gut permeability and circulating lipopolysaccharide, and in which modulating the microbiota with prebiotics reduced both. Human evidence includes increased jejunal permeability with systemic and adipose tissue endotoxaemia and inflammation in people with obesity, an association between permeability measured by serum zonulin and lipopolysaccharide, high-sensitivity C-reactive protein, fasting insulin, HOMA-IR and triglycerides in overweight pregnant women, and higher circulating zonulin in obesity-associated insulin resistance. Permeability markers correlate with visceral adiposity and with liver fat content. Interpretation is limited by assay heterogeneity (zonulin immunoassays vary and have been questioned), by confounding from diet, alcohol and medication, and by the absence of trials showing that reducing permeability produces weight loss; randomised trials of faecal microbiota transplantation in obesity have not reduced weight despite changing the microbiota. Clinically useful measures are a careful history for small intestinal bacterial overgrowth, coeliac disease, inflammatory bowel disease and alcohol use, and attention to diet quality: fibre, resistant starch, polyphenols and fermented foods support the barrier, while a high intake of ultra-processed food, emulsifiers and alcohol works against it. Commercial gut permeability panels are not recommended as a basis for treatment decisions.
Key Insight
Why It Matters
This term explains why diet quality affects metabolic health beyond calories alone. It also gives a mechanism for something patients notice in practice: a fibre-rich, less processed diet improves blood sugar, liver fat and inflammatory markers even before much weight is lost. It is worth keeping the claims modest, because the marketed gut-repair tests and supplements are not supported by good evidence, and changing the gut bacteria alone has not been shown to produce weight loss. In the clinic, the practical expression of this science is nutrition advice, not supplements.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: October 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
